Announcement of Chengdu Oulin Biotechnology Co., Ltd. on the voluntary disclosure of the quadrivalent influenza virus lytic vaccine (MDCK cells) approval notice for drug clinical trials

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.